Sign in

NCT05003960RecruitingPhase 1

Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for Autism

Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Autism

Source: ClinicalTrials.gov · Last updated 20 Oct 2026

Brief summary (registry, in English)

This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells for the treatment of Autism

Status (registry)
Recruiting
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
15 (estimated)
First submitted
6 Aug 2021
Start date
23 Jan 2022
Primary completion date
1 Dec 2027
Lead sponsor
The Foundation for Orthopaedics and Regenerative Medicine
Diseases
Autism
NCT number
NCT05003960

What you commit to

  • Study type: Interventional · Phase 1
  • Planned participants: 15
  • From 23 Jan 2022 to the primary completion date, 1 Dec 2027
  • 2 sites in 2 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous organ transplant

Other illness

  • Active infection
  • Active cancer
  • Chronic multisystem organ failure
  • Medical condition that would (based on the opinion of the investigator) compromise patient's safety
  • Seizure disorder
  • Hypersensitivity to sulfur

Lab values

  • Clinically significant Abnormalities on pre-treatment laboratory evaluation

Other

  • Pregnancy

Who the study is looking for

  • Diagnosis of Autism

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Prodromos Stem Cell Institute
Coordinator of this site? Confirm its status
AthensGreeceRecruiting
Prodromos Stem Cell Institute
Coordinator of this site? Confirm its status
NaplesUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.